Syndax Pharmaceuticals Inc - Asset Resilience Ratio

Latest as of March 2026: 46.79%

Syndax Pharmaceuticals Inc (SNDX) has an Asset Resilience Ratio of 46.79% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Syndax Pharmaceuticals Inc to assess the company's strategic physical and investment asset allocation.

Liquid Assets

$221.17 Million

Cash + Short-term Investments

Total Assets

$472.67 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2025)

This chart shows how Syndax Pharmaceuticals Inc's Asset Resilience Ratio has changed over time. See SNDX net asset quality score to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Syndax Pharmaceuticals Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Syndax Pharmaceuticals Inc (SNDX) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$221.17 Million	46.79%
Total Liquid Assets	$221.17 Million	46.79%

Asset Resilience Insights

Very High Liquidity: Syndax Pharmaceuticals Inc maintains exceptional liquid asset reserves at 46.79% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Syndax Pharmaceuticals Inc Industry Peers by Asset Resilience Ratio

Compare Syndax Pharmaceuticals Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Cyclacel Pharmaceuticals Inc NASDAQ:CYCC	Biotechnology	-55.36%
Krystal Biotech Inc NASDAQ:KRYS	Biotechnology	23.06%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for Syndax Pharmaceuticals Inc (2011–2025)

The table below shows the annual Asset Resilience Ratio data for Syndax Pharmaceuticals Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	48.92%	$259.14 Million	$529.71 Million	-10.24pp
2024-12-31	59.16%	$428.83 Million	$724.82 Million	+13.12pp
2023-12-31	46.04%	$282.19 Million	$612.88 Million	-36.42pp
2022-12-31	82.46%	$410.04 Million	$497.24 Million	+32.46pp
2021-12-31	50.01%	$224.87 Million	$449.66 Million	-9.15pp
2020-12-31	59.15%	$177.82 Million	$300.61 Million	+3.80pp
2019-12-31	55.36%	$35.17 Million	$63.52 Million	-0.81pp
2018-12-31	56.16%	$47.14 Million	$83.94 Million	-12.94pp
2017-12-31	69.11%	$94.81 Million	$137.19 Million	-5.64pp
2016-12-31	74.75%	$81.49 Million	$109.01 Million	+3.43pp
2015-12-31	71.32%	$64.11 Million	$89.90 Million	+54.16pp
2014-12-31	17.16%	$2.20 Million	$12.82 Million	-7.22pp
2013-12-31	24.38%	$4.16 Million	$17.06 Million	+18.36pp
2012-12-31	6.03%	$91.00K	$1.51 Million	-6.78pp
2011-12-31	12.81%	$613.00K	$4.79 Million	--

pp = percentage points

About Syndax Pharmaceuticals Inc

NASDAQ:SNDX USA Biotechnology

Market Cap

$1.69 Billion

Market Cap Rank

#6903 Global

#2071 in USA

Share Price

$19.04

Change (1 day)

+2.64%

52-Week Range

$8.73 - $25.15

All Time High

$28.98